Ad is loading...
CYTK
Price
$50.96
Change
+$0.56 (+1.11%)
Updated
Dec 6 closing price
74 days until earnings call
DSGN
Price
$6.40
Change
+$0.22 (+3.56%)
Updated
Dec 6, 04:59 PM (EDT)
88 days until earnings call
Ad is loading...

CYTK vs DSGN

Header iconCYTK vs DSGN Comparison
Open Charts CYTK vs DSGNBanner chart's image
Cytokinetics
Price$50.96
Change+$0.56 (+1.11%)
Volume$580.84K
CapitalizationN/A
Design Therapeutics
Price$6.40
Change+$0.22 (+3.56%)
Volume$3.9K
CapitalizationN/A
CYTK vs DSGN Comparison Chart
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
DSGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CYTK vs. DSGN commentary
Dec 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a StrongSell and DSGN is a StrongBuy.

COMPARISON
Comparison
Dec 09, 2024
Stock price -- (CYTK: $50.96 vs. DSGN: $6.41)
Brand notoriety: CYTK and DSGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 51% vs. DSGN: 60%
Market capitalization -- CYTK: $5.95B vs. DSGN: $349.92M
CYTK [@Biotechnology] is valued at $5.95B. DSGN’s [@Biotechnology] market capitalization is $349.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileDSGN’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • DSGN’s FA Score: 0 green, 5 red.
According to our system of comparison, CYTK is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 3 TA indicator(s) are bullish while DSGN’s TA Score has 5 bullish TA indicator(s).

  • CYTK’s TA Score: 3 bullish, 7 bearish.
  • DSGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, DSGN is a better buy in the short-term than CYTK.

Price Growth

CYTK (@Biotechnology) experienced а -1.74% price change this week, while DSGN (@Biotechnology) price change was +6.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -2.68%, and the average quarterly price growth was +10.76%.

Reported Earning Dates

CYTK is expected to report earnings on Feb 20, 2025.

DSGN is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($5.95B) has a higher market cap than DSGN($350M). DSGN YTD gains are higher at: 141.887 vs. CYTK (-38.963). DSGN has higher annual earnings (EBITDA): -60.23M vs. CYTK (-481.94M). CYTK has more cash in the bank: 1.01B vs. DSGN (254M). DSGN has less debt than CYTK: DSGN (2.52M) vs CYTK (790M). CYTK has higher revenues than DSGN: CYTK (3.22M) vs DSGN (0).
CYTKDSGNCYTK / DSGN
Capitalization5.95B350M1,699%
EBITDA-481.94M-60.23M800%
Gain YTD-38.963141.887-27%
P/E RatioN/AN/A-
Revenue3.22M0-
Total Cash1.01B254M398%
Total Debt790M2.52M31,324%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
46
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKDSGN
RSI
ODDS (%)
Bearish Trend 3 days ago
56%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
82%
Bullish Trend 7 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 20 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
DSGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PVIVX60.500.54
+0.90%
Paradigm Micro-Cap
NBSLX52.160.14
+0.27%
Neuberger Berman Sustainable Equity I
TRXAX11.79-0.02
-0.17%
Catalyst/MAP Global Balanced A
PRERX29.22-0.08
-0.27%
Principal Real Estate Securities R3
INFIX9.36-0.09
-0.95%
Tortoise Energy Infras and Inc Ins

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with CYTK. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
+3.72%
CYTK - DSGN
39%
Loosely correlated
+1.11%
MDGL - DSGN
38%
Loosely correlated
+2.49%
AGIO - DSGN
36%
Loosely correlated
+4.53%
RCKT - DSGN
34%
Loosely correlated
+4.28%
TERN - DSGN
33%
Loosely correlated
+1.71%
More